Asia Pacific Neuromodulation Market Size, Share & Industry Trends Analysis Report By Technology (Internal and External), By Biomaterial, By Application, By Country and Growth Forecast, 2022 - 2028

The Asia Pacific Neuromodulation Market would witness Market growth of 6.6% CAGR during the forecast period (2022-2028).

Disorders of the brain, as well as the nerves that run all through the human body and the spinal cord, are referred to as neurological disorders. Some of the most common neurological ailments are acute spinal cord injury, Alzheimer's disease, amyotrophic lateral sclerosis (ALS), ataxia, Bell’s palsy, brain tumors, cerebral aneurysms, epilepsy, and seizures. Memory loss, poor mental capacity, lack of coordination, and chronic or abrupt onset of a headache are all signs of biochemical, structural, or electrical problems in the brain, spinal cord, or other nerves. Neuromodulation technology makes use of devices that stimulate or modulate brain activity to cause a change in the nervous system. When standard treatments have failed to elicit the desired reaction, they are utilized.

The rising prevalence of chronic conditions, as well as the limitations of pharmacological medicine in effectively treating them, has paved the way for advancements in neurostimulation approaches. The functional capabilities of various nerves in the human body, as well as the consequences of electrical stimulation of these nerves for the treatment of various illnesses, are continually being researched. As a result, new strategies and techniques for addressing and treating chronic illnesses have emerged. These procedures include spinal cord stimulation for pain relief, as well as stimulation of the vagus nerve for epilepsy and other diseases. The Market is becoming more diversified by the introduction of specialized devices and techniques to treat specific illnesses, as well as continual advancements in neurostimulation techniques.

There is a significant number of developments that are going on in this region. This region also has various developing countries, such as India and China. Governments across these countries are increasing their investment of the development of their healthcare infrastructure in order to offer enhanced treatment to their citizens. In addition, the per capita disposable income of the regional people is also increasing, due to which, they are becoming able to afford various expensive and highly advanced treatment approaches.

The increasing frequency of neurological illnesses and significant innovations in neuromodulation technology in the Asia Pacific region are driving the growth of the regional neuromodulation Market . Depression affects people of all ages and is the most commonly found neurological condition.

The China Market dominated the Asia Pacific Neuromodulation Market by Country in 2021, and would continue to be a dominant Market till 2028; thereby, achieving a Market value of $305.2 million by 2028. The Japan Market is estimated to grow at a CAGR of 5.9% during (2022 - 2028). Additionally, The India Market would showcase CAGR of 7.2% during (2022 - 2028).

Based on Technology, the Market is segmented into Internal and External. Based on Biomaterial, the Market is segmented into Metallic, Polymeric, and Ceramic. Based on Application, the Market is segmented into Chronic Pain, Urinary & Fecal Incontinence, Migraine, Failed Back Syndrome, Parkinson Disease, Epilepsy, Tremor, Depression, and Others. Based on countries, the Market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.

Free Valuable Insights: The Worldwide Neuromodulation Market is Projected to reach USD 3.8 Billion by 2028, at a CAGR of 6%

The Market research report covers the analysis of key stake holders of the Market . Key companies profiled in the report include Medtronic PLC, LivaNova PLC, Boston Scientific Corporation, Abbott Laboratories, Nevro Corporation, NeuroSigma, Inc., NeuroPace, Inc., Neuronetics, Inc., MicroTransponder Inc., and Bioventus Inc.

Scope of the Study

Market Segments Covered in the Report:

By Technology

• Internal
• External

By Biomaterial

• Metallic
• Polymeric
• Ceramic

By Application

• Chronic Pain
• Urinary & Fecal Incontinence
• Migraine
• Failed Back Syndrome
• Parkinson Disease
• Epilepsy
• Tremor
• Depression
• Others

By Country

• China
• Japan
• India
• South Korea
• Singapore
• Malaysia
• Rest of Asia Pacific

Key Market Players

List of Companies Profiled in the Report:

• Medtronic PLC
• LivaNova PLC
• Boston Scientific Corporation
• Abbott Laboratories
• Nevro Corporation
• NeuroSigma, Inc.
• NeuroPace, Inc.
• Neuronetics, Inc.
• MicroTransponder Inc.
• Bioventus Inc.

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Neuromodulation Market, by Technology
1.4.2 Asia Pacific Neuromodulation Market, by Biomaterial
1.4.3 Asia Pacific Neuromodulation Market, by Application
1.4.4 Asia Pacific Neuromodulation Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Approvals and Trials
3.2.3 Product Launches and Product Expansions
3.2.4 Acquisition and Mergers
3.2.5 Geographical Expansions
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)

Chapter 4. Asia Pacific Neuromodulation Market by Technology
4.1 Asia Pacific Internal Market by Country
4.2 Asia Pacific External Market by Country

Chapter 5. Asia Pacific Neuromodulation Market by Biomaterial
5.1 Asia Pacific Metallic Market by Country
5.2 Asia Pacific Polymeric Market by Country
5.3 Asia Pacific Ceramic Market by Country

Chapter 6. Asia Pacific Neuromodulation Market by Application
6.1 Asia Pacific Chronic Pain Market by Country
6.2 Asia Pacific Urinary & Fecal Incontinence Market by Country
6.3 Asia Pacific Migraine Market by Country
6.4 Asia Pacific Failed Back Syndrome Market by Country
6.5 Asia Pacific Parkinson Disease Market by Country
6.6 Asia Pacific Epilepsy Market by Country
6.7 Asia Pacific Tremor Market by Country
6.8 Asia Pacific Depression Market by Country
6.9 Asia Pacific Others Market by Country

Chapter 7. Asia Pacific Neuromodulation Market by Country
7.1 China Neuromodulation Market
7.1.1 China Neuromodulation Market by Technology
7.1.2 China Neuromodulation Market by Biomaterial
7.1.3 China Neuromodulation Market by Application
7.2 Japan Neuromodulation Market
7.2.1 Japan Neuromodulation Market by Technology
7.2.2 Japan Neuromodulation Market by Biomaterial
7.2.3 Japan Neuromodulation Market by Application
7.3 India Neuromodulation Market
7.3.1 India Neuromodulation Market by Technology
7.3.2 India Neuromodulation Market by Biomaterial
7.3.3 India Neuromodulation Market by Application
7.4 South Korea Neuromodulation Market
7.4.1 South Korea Neuromodulation Market by Technology
7.4.2 South Korea Neuromodulation Market by Biomaterial
7.4.3 South Korea Neuromodulation Market by Application
7.5 Singapore Neuromodulation Market
7.5.1 Singapore Neuromodulation Market by Technology
7.5.2 Singapore Neuromodulation Market by Biomaterial
7.5.3 Singapore Neuromodulation Market by Application
7.6 Malaysia Neuromodulation Market
7.6.1 Malaysia Neuromodulation Market by Technology
7.6.2 Malaysia Neuromodulation Market by Biomaterial
7.6.3 Malaysia Neuromodulation Market by Application
7.7 Rest of Asia Pacific Neuromodulation Market
7.7.1 Rest of Asia Pacific Neuromodulation Market by Technology
7.7.2 Rest of Asia Pacific Neuromodulation Market by Biomaterial
7.7.3 Rest of Asia Pacific Neuromodulation Market by Application

Chapter 8. Company Profiles
8.1 Medtronic PLC
8.1.1 Company overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expenses
8.1.5 Recent strategies and developments:
8.1.5.1 Product Launches and Product Expansions:
8.1.5.2 Acquisition and Mergers:
8.2 LivaNova PLC
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Partnerships, Collaborations, and Agreements:
8.2.5.2 Approvals and Trials:
8.3 Boston Scientific Corporation
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Geographical Expansions:
8.4 Abbott Laboratories
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expense
8.4.5 Recent strategies and developments:
8.4.5.1 Product Launches and Product Expansions:
8.5 Nevro Corporation
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Regional Analysis
8.5.4 Research & Development Expense
8.5.5 Recent strategies and developments:
8.5.5.1 Approvals and Trials:
8.6 NeuroSigma, Inc.
8.6.1 Company Overview
8.6.2 Recent strategies and developments:
8.6.2.1 Partnerships, Collaborations, and Agreements:
8.7 NeuroPace, Inc.
8.7.1 Company Overview
8.7.2 Recent Strategies and Developments:
8.7.2.1 Product Launches and Product Expansions:
8.8 Neuronetics, Inc.
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Regional Analysis
8.8.4 Research & Development Expense
8.9 MicroTransponder Inc.
8.9.1 Company Overview
8.9.2 Recent strategies and developments:
8.9.2.1 Approvals and Trials:
8.10. Bioventus Inc.
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Regional Analysis
8.10.4 Research & Development Expenses
8.10.5 Recent strategies and developments:
8.10.5.1 Approvals and Trials:
8.10.5.2 Acquisition and Mergers:

TABLE 1 Asia Pacific Neuromodulation Market, 2018 - 2021, USD Million
TABLE 2 Asia Pacific Neuromodulation Market, 2022 - 2028, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Neuromodulation Market
TABLE 4 Approvals and Trials - NEUROMODULATION MARKET
TABLE 5 Product Launches And Product Expansions– Neuromodulation Market
TABLE 6 Acquisition and Mergers– Neuromodulation Market
TABLE 7 Geographical Expansions- Neuromodulation Market
TABLE 8 Asia Pacific Neuromodulation Market by Technology, 2018 - 2021, USD Million
TABLE 9 Asia Pacific Neuromodulation Market by Technology, 2022 - 2028, USD Million
TABLE 10 Asia Pacific Internal Market by Country, 2018 - 2021, USD Million
TABLE 11 Asia Pacific Internal Market by Country, 2022 - 2028, USD Million
TABLE 12 Asia Pacific External Market by Country, 2018 - 2021, USD Million
TABLE 13 Asia Pacific External Market by Country, 2022 - 2028, USD Million
TABLE 14 Asia Pacific Neuromodulation Market by Biomaterial, 2018 - 2021, USD Million
TABLE 15 Asia Pacific Neuromodulation Market by Biomaterial, 2022 - 2028, USD Million
TABLE 16 Asia Pacific Metallic Market by Country, 2018 - 2021, USD Million
TABLE 17 Asia Pacific Metallic Market by Country, 2022 - 2028, USD Million
TABLE 18 Asia Pacific Polymeric Market by Country, 2018 - 2021, USD Million
TABLE 19 Asia Pacific Polymeric Market by Country, 2022 - 2028, USD Million
TABLE 20 Asia Pacific Ceramic Market by Country, 2018 - 2021, USD Million
TABLE 21 Asia Pacific Ceramic Market by Country, 2022 - 2028, USD Million
TABLE 22 Asia Pacific Neuromodulation Market by Application, 2018 - 2021, USD Million
TABLE 23 Asia Pacific Neuromodulation Market by Application, 2022 - 2028, USD Million
TABLE 24 Asia Pacific Chronic Pain Market by Country, 2018 - 2021, USD Million
TABLE 25 Asia Pacific Chronic Pain Market by Country, 2022 - 2028, USD Million
TABLE 26 Asia Pacific Urinary & Fecal Incontinence Market by Country, 2018 - 2021, USD Million
TABLE 27 Asia Pacific Urinary & Fecal Incontinence Market by Country, 2022 - 2028, USD Million
TABLE 28 Asia Pacific Migraine Market by Country, 2018 - 2021, USD Million
TABLE 29 Asia Pacific Migraine Market by Country, 2022 - 2028, USD Million
TABLE 30 Asia Pacific Failed Back Syndrome Market by Country, 2018 - 2021, USD Million
TABLE 31 Asia Pacific Failed Back Syndrome Market by Country, 2022 - 2028, USD Million
TABLE 32 Asia Pacific Parkinson Disease Market by Country, 2018 - 2021, USD Million
TABLE 33 Asia Pacific Parkinson Disease Market by Country, 2022 - 2028, USD Million
TABLE 34 Asia Pacific Epilepsy Market by Country, 2018 - 2021, USD Million
TABLE 35 Asia Pacific Epilepsy Market by Country, 2022 - 2028, USD Million
TABLE 36 Asia Pacific Tremor Market by Country, 2018 - 2021, USD Million
TABLE 37 Asia Pacific Tremor Market by Country, 2022 - 2028, USD Million
TABLE 38 Asia Pacific Depression Market by Country, 2018 - 2021, USD Million
TABLE 39 Asia Pacific Depression Market by Country, 2022 - 2028, USD Million
TABLE 40 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
TABLE 41 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
TABLE 42 Asia Pacific Neuromodulation Market by Country, 2018 - 2021, USD Million
TABLE 43 Asia Pacific Neuromodulation Market by Country, 2022 - 2028, USD Million
TABLE 44 China Neuromodulation Market, 2018 - 2021, USD Million
TABLE 45 China Neuromodulation Market, 2022 - 2028, USD Million
TABLE 46 China Neuromodulation Market by Technology, 2018 - 2021, USD Million
TABLE 47 China Neuromodulation Market by Technology, 2022 - 2028, USD Million
TABLE 48 China Neuromodulation Market by Biomaterial, 2018 - 2021, USD Million
TABLE 49 China Neuromodulation Market by Biomaterial, 2022 - 2028, USD Million
TABLE 50 China Neuromodulation Market by Application, 2018 - 2021, USD Million
TABLE 51 China Neuromodulation Market by Application, 2022 - 2028, USD Million
TABLE 52 Japan Neuromodulation Market, 2018 - 2021, USD Million
TABLE 53 Japan Neuromodulation Market, 2022 - 2028, USD Million
TABLE 54 Japan Neuromodulation Market by Technology, 2018 - 2021, USD Million
TABLE 55 Japan Neuromodulation Market by Technology, 2022 - 2028, USD Million
TABLE 56 Japan Neuromodulation Market by Biomaterial, 2018 - 2021, USD Million
TABLE 57 Japan Neuromodulation Market by Biomaterial, 2022 - 2028, USD Million
TABLE 58 Japan Neuromodulation Market by Application, 2018 - 2021, USD Million
TABLE 59 Japan Neuromodulation Market by Application, 2022 - 2028, USD Million
TABLE 60 India Neuromodulation Market, 2018 - 2021, USD Million
TABLE 61 India Neuromodulation Market, 2022 - 2028, USD Million
TABLE 62 India Neuromodulation Market by Technology, 2018 - 2021, USD Million
TABLE 63 India Neuromodulation Market by Technology, 2022 - 2028, USD Million
TABLE 64 India Neuromodulation Market by Biomaterial, 2018 - 2021, USD Million
TABLE 65 India Neuromodulation Market by Biomaterial, 2022 - 2028, USD Million
TABLE 66 India Neuromodulation Market by Application, 2018 - 2021, USD Million
TABLE 67 India Neuromodulation Market by Application, 2022 - 2028, USD Million
TABLE 68 South Korea Neuromodulation Market, 2018 - 2021, USD Million
TABLE 69 South Korea Neuromodulation Market, 2022 - 2028, USD Million
TABLE 70 South Korea Neuromodulation Market by Technology, 2018 - 2021, USD Million
TABLE 71 South Korea Neuromodulation Market by Technology, 2022 - 2028, USD Million
TABLE 72 South Korea Neuromodulation Market by Biomaterial, 2018 - 2021, USD Million
TABLE 73 South Korea Neuromodulation Market by Biomaterial, 2022 - 2028, USD Million
TABLE 74 South Korea Neuromodulation Market by Application, 2018 - 2021, USD Million
TABLE 75 South Korea Neuromodulation Market by Application, 2022 - 2028, USD Million
TABLE 76 Singapore Neuromodulation Market, 2018 - 2021, USD Million
TABLE 77 Singapore Neuromodulation Market, 2022 - 2028, USD Million
TABLE 78 Singapore Neuromodulation Market by Technology, 2018 - 2021, USD Million
TABLE 79 Singapore Neuromodulation Market by Technology, 2022 - 2028, USD Million
TABLE 80 Singapore Neuromodulation Market by Biomaterial, 2018 - 2021, USD Million
TABLE 81 Singapore Neuromodulation Market by Biomaterial, 2022 - 2028, USD Million
TABLE 82 Singapore Neuromodulation Market by Application, 2018 - 2021, USD Million
TABLE 83 Singapore Neuromodulation Market by Application, 2022 - 2028, USD Million
TABLE 84 Malaysia Neuromodulation Market, 2018 - 2021, USD Million
TABLE 85 Malaysia Neuromodulation Market, 2022 - 2028, USD Million
TABLE 86 Malaysia Neuromodulation Market by Technology, 2018 - 2021, USD Million
TABLE 87 Malaysia Neuromodulation Market by Technology, 2022 - 2028, USD Million
TABLE 88 Malaysia Neuromodulation Market by Biomaterial, 2018 - 2021, USD Million
TABLE 89 Malaysia Neuromodulation Market by Biomaterial, 2022 - 2028, USD Million
TABLE 90 Malaysia Neuromodulation Market by Application, 2018 - 2021, USD Million
TABLE 91 Malaysia Neuromodulation Market by Application, 2022 - 2028, USD Million
TABLE 92 Rest of Asia Pacific Neuromodulation Market, 2018 - 2021, USD Million
TABLE 93 Rest of Asia Pacific Neuromodulation Market, 2022 - 2028, USD Million
TABLE 94 Rest of Asia Pacific Neuromodulation Market by Technology, 2018 - 2021, USD Million
TABLE 95 Rest of Asia Pacific Neuromodulation Market by Technology, 2022 - 2028, USD Million
TABLE 96 Rest of Asia Pacific Neuromodulation Market by Biomaterial, 2018 - 2021, USD Million
TABLE 97 Rest of Asia Pacific Neuromodulation Market by Biomaterial, 2022 - 2028, USD Million
TABLE 98 Rest of Asia Pacific Neuromodulation Market by Application, 2018 - 2021, USD Million
TABLE 99 Rest of Asia Pacific Neuromodulation Market by Application, 2022 - 2028, USD Million
TABLE 100 Key Information – Medtronic PLC
TABLE 101 Key Information – LivaNova PLC
TABLE 102 key Information – Boston Scientific Corporation
TABLE 103 Key Information – Abbott Laboratories
TABLE 104 Key Information – Nevro Corporation
TABLE 105 key Information – NeuroSigma, Inc.
TABLE 106 Key Information – NeuroPace, Inc.
TABLE 107 Key Information – Neuronetics, Inc.
TABLE 108 Key Information – MicroTransponder Inc.
TABLE 109 Key Information – Bioventus Inc.

List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2018-2022)
FIG 4 Recent strategies and developments: Medtronic PLC
FIG 5 Recent strategies and developments: Bioventus Inc.